Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-HYDROMORPHONE CR APOTEX INC Resolved 9MG Updated Report 2020-04-04 71127
APO-HYDROMORPHONE CR APOTEX INC Resolved 6MG Updated Report 2020-04-04 71124
APO-HYDROMORPHONE CR APOTEX INC Resolved 24MG Updated Report 2020-04-04 79039
APO-HYDROMORPHONE CR APOTEX INC Resolved 3MG Updated Report 2020-04-04 74019
APO-HYDROMORPHONE CR APOTEX INC Resolved 30MG Updated Report 2020-04-04 77858
APO-HYDROMORPHONE CR APOTEX INC Resolved 24MG Updated Report 2020-04-04 77855
APO-HYDROMORPHONE CR APOTEX INC Resolved 18MG Updated Report 2020-04-04 77852
APO-HYDROMORPHONE CR APOTEX INC Resolved 12MG Updated Report 2020-04-04 77849
APO-HYDROMORPHONE CR APOTEX INC Resolved 4.5MG Updated Report 2020-04-04 98562
ONE ALPHA CAPS 1MCG LEO PHARMA INC Anticipated shortage 1MCG New Report 2020-04-04 110953

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-HYDROMORPHONE CR APOTEX INC Discontinued 9MG New Report 2020-04-04 110977
APO-HYDROMORPHONE CR APOTEX INC Discontinued 4.5MG New Report 2020-04-04 110974
APO-HYDROMORPHONE CR APOTEX INC Discontinued 30MG New Report 2020-04-04 110971
APO-HYDROMORPHONE CR APOTEX INC Discontinued 24MG New Report 2020-04-04 110968
APO-HYDROMORPHONE CR APOTEX INC Discontinued 18MG New Report 2020-04-04 110965
APO-HYDROMORPHONE CR APOTEX INC Discontinued 12MG New Report 2020-04-04 110962
APO-HYDROMORPHONE CR APOTEX INC Discontinued 6MG New Report 2020-04-04 110959
APO-HYDROMORPHONE CR APOTEX INC Discontinued 3MG New Report 2020-04-04 110956
CIPRO BAYER INC To be discontinued 500MG Updated Report 2020-04-02 96049
SANDOZ DILTIAZEM T SANDOZ CANADA INCORPORATED Discontinued New Report 2020-04-01 110324
ZERIT - CAP 15MG BRISTOL-MYERS SQUIBB CANADA Discontinued 15MG Updated Report 2020-04-01 55453
POLYTOPIC SANDOZ CANADA INCORPORATED Discontinued 500UNIT 10000UNIT New Report 2020-04-01 110309
ZERIT - CAP 20MG BRISTOL-MYERS SQUIBB CANADA Discontinued 20MG Updated Report 2020-04-01 55456
ZERIT - CAP 30MG BRISTOL-MYERS SQUIBB CANADA Discontinued 30MG Updated Report 2020-04-01 55459
ZERIT - CAP 40MG BRISTOL-MYERS SQUIBB CANADA Discontinued 40MG Updated Report 2020-04-01 55462
VIDEX EC BRISTOL-MYERS SQUIBB CANADA Discontinued 125MG Updated Report 2020-04-01 55440
VIDEX EC BRISTOL-MYERS SQUIBB CANADA Discontinued 200MG Updated Report 2020-04-01 55443
VIDEX EC BRISTOL-MYERS SQUIBB CANADA Discontinued 250MG Updated Report 2020-04-01 55446
VIDEX EC BRISTOL-MYERS SQUIBB CANADA Discontinued 400MG Updated Report 2020-04-01 55449
BRETYLIUM TOSYLATE INJECTION USP SANDOZ CANADA INCORPORATED Discontinued New Report 2020-04-01 110288